July 29, 2014 by Arezu Sarvestani
California-based Proteus Digital Health closed a Series G funding round this week with more than $172 million pledged in support of the company’s ingestible sensor-laden pills.
Proteus called the private financing round the largest this year for digital health and one of the largest this year in any industry. The company said that the latest fundraising effort also lured new “respected institutional investors” to the growth equity round. Read more
July 25, 2014 by Arezu Sarvestani
Minnesota device maker issued a series of updates this month on its legal and financial dealings, including that it secured more than $733,000 to help pay for its corporate expenses.
In an SEC filing dated July 23, Skyline revealed that it had raised funds from 2 unnamed investors to pay “salary and stipends due to officers and directors.” The funds were raised through sales of debt, rights and securities, according to the filing. Read more
July 28, 2014 by Arezu Sarvestani
Massachusetts-based Augmenix is hoping it can make it to the U.S. market with the $10.8 million funding round it just closed, the company said this month.
The company expects to launch its SpaceOAR system “in earnest” next year, counting on a successful bid for FDA approval. The SpaceOAR hydrogel product helps separate the rectum from the prostate during radiation therapy, allowing physicians to use higher doses of radiation to attack cancerous cells while protecting healthy tissue. Read more